Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 4
  • 15
  • 22
  • 11
  • 15
  • 7

Found 22 obstetrics-and-gynecology trials

A listing of obstetrics-and-gynecology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 The POLAR Trial - Positive End-Expiratory Pressure (PEEP) Levels during Resuscitation of Preterm Infants at Birth

The POLAR Trial - Positive End-Expiratory Pressure (PEEP) Levels during Resuscitation of Preterm Infants at Birth

All genders
Phase 3
Interventional
The POLAR Trial - Positive End-Expiratory Pressure (PEEP) Levels during Resuscitation of Preterm Infants  at Birth
 Cervical Ripening as an Outpatient Method Using the Foley: A Randomized Trial (COMFORT)

Cervical Ripening as an Outpatient Method Using the Foley: A Randomized Trial (COMFORT)

18-55 years
Female
Induction of labor normally starts in the hospital. The purpose of this research study is to look at starting your induction at home and see if it lowers your chances of having a c-section compared to starting your induction in the hospital. First time moms are being asked to volunteer …
 The REACTIVE Trial

The REACTIVE Trial

18-50 years
Female
The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring.

Penn Uterine Transplantation for Uterine Factor Infertility (UNTIL) Trial

21-40 years
Female
The UNTIL Trial is a new clinical research trial that offers uterine transplantation to women with uterine factor infertility (UFI). Participation in this trial requires going through an extensive selection process, creation of embryos through in vitro fertilization, and multiple surgeries. Study participants may remain in the study for 5-10 …
 Environmental influences on Child Health Outcomes

Environmental influences on Child Health Outcomes (ECHO)

Female
ECHO stands for Environmental influences on Child Health Outcomes. ECHO is a large research program supported by the National Institutes of Health that aims to improve the health of children and teens in the United States. ECHO will enroll more than 50,000 women, men, babies, children, and teens to partner …
 Continuation of the nuMoM2b Heart Health Study

Continuation of the nuMoM2b Heart Health Study (nuMoM2b-HHS2)

18-99 years
Female
Interventional
The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively collected for up to 7 years thereafter. The overarching scientific goal of this study is to define the relationship between adverse pregnancy outcomes …

APPLE

99 years and younger
All genders
Please refer to Protocol section 3, Study Objectives and Endpoints Please refer to Protocol section 3, Study Objectives and Endpoints Please refer to Protocol section 3, Study Objectives and Endpoints

A Study of ZN-c3 in Subjects With High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

18 years and older
All genders
The purpose of this study includes the following: ·         To test the efficacy and safety of the Study Drug and to find out what effects, good and/or bad, it has on you and your cancer. ·         To understand how the body absorbs and processes the Study Drug by measuring the …

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer (NRG-GY031)

18-99 years
Female
Phase 1
To determine the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) for combination of ATR inhibitor (M1774) and BET inhibitor (ZEN003694) in women with recurrent clear cell, endometrioid, and platinum resistant high grade serous ovarian carcinoma (HGSOC) and clear cell and endometrioid endometrial carcinoma irrespective of ARID1A status.The target …
1 - 10 of 22